IT News Online - Jolt Health To Acquire HCQ Transdermal Patch Technology
Jolt Health To Acquire HCQ Transdermal Patch Technology
Stay updated with breaking news from Address Underserved Lupus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jolt Health To Acquire HCQ Transdermal Patch Technology
FDA Approved and Viability to Address Underserved Lupus, Rheumatoid Arthritis and Malaria market, forecast to be worth $6 Billion USD by 2027* ...
Jolt Health To Acquire HCQ Transdermal Patch Technology
Codebase Ventures Inc.: Codebase Receives Positive Technical Study Results for HCQ Transdermal Patch Technology Viability to Address Underserved Lupus, Rheumatoid Arthritis and Malaria market, forecast to be worth $6 Billion USD by 2027*, Company to investigate Spin Out of Asset VANCOUVER, BC / ACCESSWIRE / April 1, 2021 / Codebase Ventures Inc. ("Codebase" or the "Company") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to provide an update on the continued development of the Company's proposed transdermal delivery technology for hydroxychloroquine (HCQ), as first announced in April 2020. The C...